ArticleAntimicrobial agents and chemotherapy2006
Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 65 citations in OpenAlex.
- CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.The Journal of antimicrobial chemotherapy · 2023Article
- Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-ResistantFrontiers in microbiology · 2021Review
- Resistance ofFrontiers in microbiology · 2018Article
- [Enterococci and surgical site infections : Causal agent or harmless commensals?]Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2017Review
- Novel Structural Components Contribute to the High Thermal Stability of Acyl Carrier Protein from Enterococcus faecalis.The Journal of biological chemistry · 2016Article
- Article
- The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure.Avicenna journal of medicine · 2014Article
- Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012Article
- Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.Bioorganic & medicinal chemistry · 2012Article
- Flow cytometry approach study of Enterococcus faecalis vancomycin resistance by detection of Vancomycin@FL binding to the bacterial cells.Current microbiology · 2010Article
- New antibiotics for antibiotic-resistant bacteria.F1000 biology reports · 2009Article
- R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.Antimicrobial agents and chemotherapy · 2008Article
- In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.Antimicrobial agents and chemotherapy · 2008Article
- Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization.Journal of clinical microbiology · 2007Article
- Response to emerging infection leading to outbreak of linezolid-resistant enterococci.Emerging infectious diseases · 2007Article
- [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology].Der Anaesthesist · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the emergence of linezolid resistance (MICs of 16 to 32 mg/liter) in clonally related vancomycin-susceptible and -resistant Enterococcus faecium isolates from an intensive care unit patient after 12 days of linezolid therapy. Only linezolid-susceptible isolates of the same clone were detected at 28 days after termination of linezolid therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.